ArticleDrug design, development and therapy2021

Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus.

Fangfang Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.